6.04MCAD
Type
Common Stock
Exchange
V
Currency Code
CAD
Currency Name
Canadian Dollar
Country Name
Canada
Country ISO
CA
ISIN
CA4838092084
CUSIP
483809208
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.01
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.02
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
2,441,506
Gross Profit TTM
874,492
EBITDA
-3,631,641
Profit Margin
257.02%
Return On Assets TTM
-53.93%
Return On Equity TTM
-596.80%
Revenue Per Share TTM
0.018
Qtly Revenue Growth YOY
695.00%
Diluted Eps TTM
-0.02
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
3.3949
Price Book MRQ
104.3821
Enterprise Value Revenue
4
Enterprise Value EBITDA
-6
0.59
1.72%1.01
1.00%0.84
-4.55%7.20
-3.10%11.64
-2.84%1.73
-2.81%11.35
-2.16%3.75
-1.32%1.73
-1.14%4.30
-0.46%